Citation: | WANG Dan, BAO Kun, LIU Juan, MA Weizhong, WANG Rongrong, XU Xiaona, SUN Na, QIN Xindong. Peritoneal dialysis-related peritonitis dominated by pandrug-resistant Klebsiella pneumoniae: a case report[J]. Chinese Journal of General Practice, 2023, 21(8): 1441-1443. doi: 10.16766/j.cnki.issn.1674-4152.003141 |
[1] |
沈水娟, 官继超, 王时敏, 等. 129例次腹膜透析相关性腹膜炎的致病菌分布及药敏分析[J]. 中华全科医学, 2018, 16(10): 1662-1666. doi: 10.16766/j.cnki.issn.1674-4152.000453
SHEN S J, GUAN J C, WANG S M, et al. Analysis of microbial spectrum and antibiotic resistance in 129 cases patients of peritoneal dialysis related peritonitis[J]. Chinese Journal of General Practice, 2018, 16(10): 1662-1666. doi: 10.16766/j.cnki.issn.1674-4152.000453
|
[2] |
LIN W H, TSENG C C, WU A B, et al. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Klebsiella pneumoniae in southern Taiwan[J]. J Microbiol Immunol Infect, 2015, 48(3): 276-283. doi: 10.1016/j.jmii.2013.10.002
|
[3] |
刘美婷, 戴欢子, 王玲. 单中心14年腹膜透析相关性腹膜炎病原菌谱变化趋势分析[J]. 陆军军医大学学报, 2022, 44(23): 2435-2439. https://www.cnki.com.cn/Article/CJFDTOTAL-DSDX202223011.htm
LIU M T, DAI H Z, WANG L. Changing trends in pathogenic bacteria spectrum of peritoneal dialysis-related peritonitis in a single center in 14 years[J]. Journal of Army Medical University, 2022, 44(23): 2435-2439. https://www.cnki.com.cn/Article/CJFDTOTAL-DSDX202223011.htm
|
[4] |
LI P K, CHOW K M, CHO Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment[J]. Perit Dial Int, 2022, 42(2): 110-153. doi: 10.1177/08968608221080586
|
[5] |
VIKRANT S, GULERIA R C. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae causing peritonitis in a patient on continuous ambulatory peritoneal dialysis[J]. Saudi J Kidney Dis Transpl, 2014, 25(4): 888-889. doi: 10.4103/1319-2442.135202
|
[6] |
SANDHU A, ZHENG S. A case report of expanded-spectrum beta-lactamase-producing Klebsiella pneumoniae peritonitis in a patient on continuous ambulatory peritoneal dialysis[J]. Perit Dial Int, 2012, 32(2): 229-230. doi: 10.3747/pdi.2011.00108
|
[7] |
SINHA R, BHAKTA A. Extended spectrum beta lactamase peritonitis: time for innovation?[J]. Indian J Nephrol, 2012, 22(5): 374-376. doi: 10.4103/0971-4065.103926
|
[8] |
PARCHURI S, MOHAN S, CUNHA B A. Extended spectrum beta-lactamase-producing Klebsiella pneumoniae chronic ambulatory peritoneal dialysis peritonitis treated successfully with polymyxin B[J]. Heart Lung, 2005, 34(5): 360-363. doi: 10.1016/j.hrtlng.2004.11.001
|
[9] |
YANG C C, CHUANG F R, HSU K T, et al. Expanded-spectrum beta-lactamase producing Klebsiella pneumoniae-related peritonitis in a patient on peritoneal dialysis[J]. Am J Kidney Dis, 2004, 44(6): e102-e106. doi: 10.1053/j.ajkd.2004.08.037
|
[10] |
O'RIORDAN J, BHALLY H S, SALMON A H, et al. Successful treatment of carbapenemase producing Enterobacteriaceae peritonitis: 'Old therapy for a new bug'[J]. Perit Dial Int, 2020, 40(1): 100-102. doi: 10.1177/0896860819879879
|
[11] |
RYANPUTRA D, WANG D, LEE M B, et al. Peritoneal dialysis-related peritonitis from carbapenemase-producing Klebsiella pneumoniae with OXA-48 type gene[J]. Perit Dial Int, 2019, 39(1): 97-98. doi: 10.3747/pdi.2018.00234
|
[12] |
MOSO M A, MACESIC N. Peritoneal dialysis-related peritonitis with carbapenem-resistant Klebsiella pneumoniae and vancomycin-resistant enterococcus faecium[J]. Open Forum Infect Dis, 2021, 8(1): ofaa525. DOI: 10.1093/ofid/ofaa525.
|
[13] |
黄展超. 成人耐碳青霉烯类肺炎克雷伯菌血流感染临床特征及死亡危险因素分析[D]. 南昌: 南昌大学, 2022.
HUANG Z C. Clinical characteristics and mortality risk factors of carbapenem-resistant klebsiella pheumoniar bloodstream infection in Adults[D]. Nanchang: Nanchang University, 2022.
|
[14] |
BRATU S, TOLANEY P, KARUMUDI U, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents[J]. J Antimicrob Chemother, 2005, 56(1): 128-132. doi: 10.1093/jac/dki175
|
[15] |
王珊珊, 吴忠伟, 赵建平. 耐碳青霉烯类肺炎克雷伯菌医院感染、耐药性及治疗的研究进展[J]. 中国抗生素杂志, 2020, 45(5): 428-432. doi: 10.3969/j.issn.1001-8689.2020.05.005
WANG S S, WU Z W, ZHAO J P. Advances in research on nosocomial infection, drug resistance and treatment of carbapenem-resistant Klebsiella pneumoniae[J]. Chinese Journal of Antibiotics, 2020, 45(5): 428-432. doi: 10.3969/j.issn.1001-8689.2020.05.005
|
[16] |
沈水娟, 王时敏, 官继超, 等. 单中心腹膜透析患者的转归及其退出原因分析[J]. 中华全科医学, 2019, 17(8): 1331-1334. doi: 10.16766/j.cnki.issn.1674-4152.000936
SHEN S J, WANG S M, GUAN J C, et al. The analysis of outcomes and dropout causes in peritoneal dialysis patients in a medical center[J]. Chinese Journal of General Practice, 2019, 17(8): 1331-1334. doi: 10.16766/j.cnki.issn.1674-4152.000936
|
[17] |
董晓, 吴海珊, 余学清, 等. 腹膜透析早期技术失败及其危险因素的研究进展[J]. 中华肾脏病杂志, 2022, 38(2): 144-150.
DONG X, WU H S, YU X Q, et al. Research progress of technique failure and its risk factors in early peritoneal dialysis[J]. Chinese Journal of Nephrology, 2022, 38(2): 144-150.
|
[18] |
胡晓熠, 汪明, 王惠明. 高通量测序技术在尿路感染及腹膜透析相关腹膜炎病原学诊断中的价值[J]. 中华实用诊断与治疗杂志, 2021, 35(3): 230-233. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202103004.htm
HU X Y, WANG M, WANG H M. Application of high-throughput sequencing technology in etiological diagnosis of urinary tract infection and peritoneal dialysis-associated peritonitis[J]. Journal of Chinese Practical Diagnosis and Therapy, 2021, 35(3): 230-233. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202103004.htm
|
[19] |
谭艳红, 陈进忠, 钟少鑫, 等. 维持性腹膜透析患者低血白蛋白水平及持续时间对新发腹膜透析相关性腹膜炎影响的多中心研究[J]. 中华肾脏病杂志, 2022, 38(7): 597-604.
TAN Y H, CHEN J Z, ZHONG S X, et al. A multicenter study on effect of low serum albumin levels and duration on first episode of peritonitis in continuous ambulatory peritoneal dialysis[J]. Chinese Journal of Nephrology, 2022, 38(7): 597-604.
|
[20] |
易春燕, 林建雄, 于晓丽, 等. 胃肠道疾病与腹膜透析相关性腹膜炎的相关性[J]. 中华肾脏病杂志, 2020, 36(12): 918-924.
YI C Y, LIN J X, YU X L, et al. Correlation between gastrointestinal diseases and peritoneal dialysis-associated peritonitis[J]. Chinese Journal of Nephrology, 2020, 36(12): 918-924.
|